Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia

European Journal of Cancer

Volumn 29, Issue 13, 1993, Pages 1839-1843

  Jankovic, Momcilo ^a   Fraschini, Donatella ^a   Amici, Augusto ^b   Aricò, Maurizio ^c   Arrighini, Alberto ^d   Basso, Giuseppe ^e   Colella, Roberto ^f   Teresa DiTullio, Maria ^g   Haupt, Riccardo ^h   Macchia, Pierantonio ⁱ   Magro, Saverio ^j   Mancini, Antonia ^k   Manganini, Carla ^a   Meloni, Giovanna ^l   Miniero, Roberto ^m   Rosso, Paolo ^m   Saracco, Paola ^m   Terracini, Benedetto ^m   Masera, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

^j Ospedale di Catanzaro   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECOND CANCER;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASMS, SECOND PRIMARY; RECURRENCE; REMISSION INDUCTION; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TREATMENT OUTCOME;

EID: 0027493773     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(93)90533-L     Document Type: Article

References (23)

1. A reappraisal of the results of stopping therapy in childhood leukemia
2. Relapse rate after cessation of therapy in childhood leukaemia
3. Discontinuing therapy in childhood acute lymphocytic leukemia
4. Acute lymphoblastic leukemia: current status of therapy in children
5. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia
6. Second malignant neoplasms in children: an update from the late effects study group
7. Nonleukaemic second malignancies following childhood acute lymphocytic leukemia
8. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia: a 13 years experience from the Dana-Farber Cancer Institute and the Children's Hospital
9. Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre study
10. Tumors of the brain and nervous system after radiotherapy in childhood
11. Brain tumors as second malignancies in children treated for acute lymphoblastic leukemia
12. Second neoplasms after acute lymphoblastic leukemia in childhood
13. Italian registry of patients off-therapy after childhood acute lymphoblastic leukemia
14. Treating childhood acute lymphoblastic leukemia (ALL): summary of ten years' experiences in Italy
15. The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia
16. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
17. Differences in prognosis for boys and girls with acute lymphoblastic leukemia
18. Sex and other prognostic factors in acute lymphoblastic leukemia in childhood
19. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries
20. Second malignant neoplasms
21. Second primaries in children with CNS tumors
22. Cancer in relatives of children with CNS neoplasms
23. Which treatment for childhood acute lymphoblastic leukemia in second remission?